UBLII LTD
Significant control: Alicia Eileen Graham (25–50%), Piotr Hapeta (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Ublii Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
UBLII LTD is an active private limited company (company number 14009760) incorporated on 29 March 2022, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of £24k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 1501% on the prior period (£1,490).
By net assets it sits in the upper half of 603 comparable companies in London (median £440, upper quartile £92k).
Ownership and control
- Miss Alicia Eileen Graham
- owns 25–50% of shares
- holds 25–50% of voting rights
- Dr. Piotr Hapeta
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 29 March 20224 yrs ago
- Next accounts due
- 31 December 2026in 69 days
- Confirmation statement due
- 12 April 2027in 171 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £24k | — | — | £26k | — | — | 1 |
| 31 March 2024 | £1,490 | — | — | £9,399 | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £23,849 at 31 March 2025
- Net assets up 10% or more on the prior period+1500.6% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.02
- Incorporated two to five years agoIncorporated 29 March 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 171 days
- Next accounts duein 69 days
- Accounts period endNet assets £24k · micro accounts
- Accounts period endNet assets £1,490 · micro accounts
- Incorporated
Similar companies in London
- LONGAEVUS TECHNOLOGIES LTDLondon · inc. Mar 2022
- CB INNOVATIONS LIMITEDLondon · inc. Apr 2022
- COPPTECH UK LIMITEDLondon · inc. Mar 2022
- MITOTECH LTDLondon · inc. Apr 2022
- QUOTIENT THERAPEUTICS LIMITEDLondon · inc. Apr 2022
- MY-T BIO LIMITEDLondon · inc. Mar 2022
All companies incorporated on 29 March 2022 · in Mar 2022.
Reminders for UBLII LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.